1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...
Cancer Res (2023) 83 (7_Supplement): ND02.
Abstract. Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: an EBCTCG meta-analysis of individual patient data from 12 randomised ...
Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...
1Novelty Nobility, lnc., Seongnam-si, Republic of Korea.
Xavier University of Louisiana, New Orleans, LA.
1School of Medicine, University of California San Diego, La Jolla, California. *Corresponding Author: James T. Robinson, School of Medicine, University of California ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts. 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. 3Ludwig MIT Center for Molecular ...
Background:. A critical component of oncogenesis and cancer progression is metabolic re-programming of cells to enable continuous growth. Oncogenic activated signaling pathways can drive de novo ...
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback